![(2R)-2-[4-(9-bromo-2,3-dimethylnaphtho[2,3-b]thiophen-4-yl)-2,6-dimethylphenoxy]-3-phenylpropanoic…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F328073-2r-2-4-9-bromo-23-dimethylnaphtho-23-b-thiophen-4-yl-26-dimethylphenoxy-3-phenylpropanoic-acid.webp&w=3840&q=75)
CAS 251303-04-5: (2R)-2-[4-(9-bromo-2,3-dimethylnaphtho[2,3-b]thiophen-4-yl)-2,6-dimethylphenoxy]-3-phenylpropanoic acid
Formula:C31H27BrO3S
InChI:InChI=1/C31H27BrO3S/c1-17-14-22(15-18(2)29(17)35-25(31(33)34)16-21-10-6-5-7-11-21)27-23-12-8-9-13-24(23)28(32)30-26(27)19(3)20(4)36-30/h5-15,25H,16H2,1-4H3,(H,33,34)/t25-/m1/s1
SMILES:Cc1cc(cc(C)c1O[C@H](Cc1ccccc1)C(=O)O)c1c2ccccc2c(c2c1c(C)c(C)s2)Br
Synonyms:- benzenepropanoic acid, alpha-[4-(9-bromo-2,3-dimethylnaphtho[2,3-b]thien-4-yl)-2,6-dimethylphenoxy]-, (alphaR)-
Sort by
Found 4 products.
Ertiprotafib
CAS:Ertiprotafib is a natural drug that inhibits the activity of enzymes involved in the synthesis of fatty acids and proteins. Ertiprotafib has been shown to inhibit phosphatase, acetylcholinesterase, hydroxylase, and phosphodiesterase. The inhibition of these enzymes leads to an increase in messenger RNA levels and protein production by cells. This drug also has anti-cancer properties. Clinical studies have shown that Ertiprotafib improves diabetic patients’ glucose tolerance and reduces insulin resistance.Formula:C31H27BrO3SPurity:Min. 95%Molecular weight:559.5 g/molErtiprotafib
CAS:Ertiprotafib (PTP 112), a PTP1B and IKK-β inhibitor, is a novel insulin sensitizer for the study of type 2 diabetes and breast cancer.Formula:C31H27BrO3SPurity:98.38%Color and Shape:SolidMolecular weight:559.51
